These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 29890736)

  • 41. Cyclooxygenase-2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents.
    Lin CK; Tseng CK; Wu YH; Liaw CC; Lin CY; Huang CH; Chen YH; Lee JC
    Sci Rep; 2017 Mar; 7():44701. PubMed ID: 28317866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity of andrographolide against dengue virus.
    Panraksa P; Ramphan S; Khongwichit S; Smith DR
    Antiviral Res; 2017 Mar; 139():69-78. PubMed ID: 28034742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of novel diarylpyrazolylquinoline derivatives as potent anti-dengue virus agents.
    Lee JC; Tseng CK; Lin CK; Tseng CH
    Eur J Med Chem; 2017 Dec; 141():282-292. PubMed ID: 29031073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C.
    Zeuzem S; Buggisch P; Agarwal K; Marcellin P; Sereni D; Klinker H; Moreno C; Zarski JP; Horsmans Y; Mo H; Arterburn S; Knox S; Oldach D; McHutchison JG; Manns MP; Foster GR
    Hepatology; 2012 Mar; 55(3):749-58. PubMed ID: 22006408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bovine Lactoferrin Inhibits Dengue Virus Infectivity by Interacting with Heparan Sulfate, Low-Density Lipoprotein Receptor, and DC-SIGN.
    Chen JM; Fan YC; Lin JW; Chen YY; Hsu WL; Chiou SS
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunomodulatory activities of IFN-gamma1b in combination with type I IFN: implications for the use of IFN-gamma1b in the treatment of chronic HCV infections.
    Wang T; Blatt LM; Seiwert SD
    J Interferon Cytokine Res; 2006 Jul; 26(7):473-83. PubMed ID: 16800786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C.
    Ross AS; Bhan AK; Pascual M; Thiim M; Benedict Cosimi A; Chung RT
    Clin Transplant; 2004 Apr; 18(2):166-73. PubMed ID: 15016131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carnosine exhibits significant antiviral activity against Dengue and Zika virus.
    Rothan HA; Abdulrahman AY; Khazali AS; Nor Rashid N; Chong TT; Yusof R
    J Pept Sci; 2019 Aug; 25(8):e3196. PubMed ID: 31290226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repurposing of prochlorperazine for use against dengue virus infection.
    Simanjuntak Y; Liang JJ; Lee YL; Lin YL
    J Infect Dis; 2015 Feb; 211(3):394-404. PubMed ID: 25028694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.
    Markland W; McQuaid TJ; Jain J; Kwong AD
    Antimicrob Agents Chemother; 2000 Apr; 44(4):859-66. PubMed ID: 10722482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cordycepin Inhibits Virus Replication in Dengue Virus-Infected Vero Cells.
    Panya A; Songprakhon P; Panwong S; Jantakee K; Kaewkod T; Tragoolpua Y; Sawasdee N; Lee VS; Nimmanpipug P; Yenchitsomanus PT
    Molecules; 2021 May; 26(11):. PubMed ID: 34071102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferon lambda inhibits dengue virus replication in epithelial cells.
    Palma-Ocampo HK; Flores-Alonso JC; Vallejo-Ruiz V; Reyes-Leyva J; Flores-Mendoza L; Herrera-Camacho I; Rosas-Murrieta NH; Santos-López G
    Virol J; 2015 Sep; 12():150. PubMed ID: 26411318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
    Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation.
    Pungpapong S; Aqel BA; Koning L; Murphy JL; Henry TM; Ryland KL; Yataco ML; Satyanarayana R; Rosser BG; Vargas HE; Charlton MR; Keaveny AP
    Liver Transpl; 2013 Jul; 19(7):690-700. PubMed ID: 23696372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.
    Chew MF; Tham HW; Rajik M; Sharifah SH
    J Appl Microbiol; 2015 Oct; 119(4):1170-80. PubMed ID: 26248692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infection.
    Yeh ML; Hsieh MY; Huang CI; Huang CF; Hsieh MH; Huang JF; Dai CY; Chuang WL; Yu ML
    J Gastroenterol Hepatol; 2016 Apr; 31(4):835-41. PubMed ID: 26478984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypes.
    Hassandarvish P; Oo A; Jokar A; Zukiwski A; Proniuk S; Abu Bakar S; Zandi K
    J Antimicrob Chemother; 2017 Sep; 72(9):2438-2442. PubMed ID: 28666323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target.
    Howe MK; Speer BL; Hughes PF; Loiselle DR; Vasudevan S; Haystead TA
    Antiviral Res; 2016 Jun; 130():81-92. PubMed ID: 27058774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two-year interferon therapy with or without ribavirin in chronic delta hepatitis.
    Gunsar F; Akarca US; Ersoz G; Kobak AC; Karasu Z; Yuce G; Ilter T; Batur Y
    Antivir Ther; 2005; 10(6):721-6. PubMed ID: 16218171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes.
    Testoni B; Durantel D; Lebossé F; Fresquet J; Helle F; Negro F; Donato MF; Levrero M; Zoulim F
    Gut; 2016 Apr; 65(4):672-82. PubMed ID: 26082258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.